Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yu I Naymann"'
Autor:
A. A. Ageev, M. V. Kozhevnikova, A. V. Emelyanov, A. V. Krivova, Yu. F. Shumskaya, L. M. Musaeva, L. V. Popova, Yu. I. Naymann, G. B. Abdullaeva, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Kardiologiia. 62:23-29
Aim To evaluate functional changes in the heart in the long-term following COVID-19 in patients with chronic heart failure (CHF).Material and methods Case reports of 54 patients aged 69.1±9.7 years who had COVID-19 from January 2021 through January
Autor:
Yu N Belenkov, Yu I Naymann, I S Ilgisonis, A M Lyamin, N V Ogorodnikov, N V Khabarova, E O Korobkova, E. V. Privalova, M V Kozhevnikova, Yu Yu Kirichenko
Publikováno v:
Kardiologiia. 60:89-95
Objective. To evaluate and study the dynamics of endothelial dysfunction instrumental indicators, vascular wall stiffness and microcirculation state in patients with gastric cancer (adenocarcinoma) before and after chemotherapy; compare it with the r
Autor:
L. I. Olbinskaya, Yu. I. Naymann
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 6, Iss 1, Pp 61-67 (2007)
Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study include
Externí odkaz:
https://doaj.org/article/b3779c40bcb3437ea2235c963411e6a3
Autor:
A A Shchendrigina, M G Mnatsakanyan, Yu N Belenkov, A H Bytdaeva, Yu I Naymann, Yu A Danilogorskaya, A O Iusupova, V Yu Zektser, N V Khabarova, E S Starostina, E A Zheleznykh, A Yu Suvorov, O V Lyapidevskaya, E. V. Privalova, K. A. Zhbanov
Publikováno v:
Kardiologiia. 60(11)
Chronic heart failure (CHF) with preserved ejection fraction (CHFpEF) is an unsolved, socially relevant challenge since it is associated with a high level of morbidity and mortality. Early markers for this pathology are unavailable, and therapeutic a
Autor:
O V Novikova, Yu Yu Kirichenko, Yu I Naymann, E. V. Privalova, I S Ilgisonis, E P Gitel, Yu N Belenkov
Publikováno v:
Kardiologiia. 60(5)
Aim To evaluate dynamics of biomarkers for endothelial dysfunction (ED), including endothelin-1 (ET-1) and von Willebrand factor (VWF) in patients with stomach cancer (adenocarcinoma) before and after polychemotherapy (PCT); to compare these results
Autor:
G. A. Shakaryants, Yu I Naymann, M V Kozhevnikova, I S Ilgisonis, V A Shakaryants, N V Khabarova, Y N Belenkov, E. V. Privalova, V. Y. Kaplunova
Publikováno v:
Kardiologiia. 17:16-24
The issues of epidemiology and pathophysiology of hypertrophic cardiomyopathy (HCMP), as well as the search for its additional clinical-instrumental and genetic markers, environmental factors capable to influence the formation of its clinical variant
Publikováno v:
Kardiologiia. 59(10)
Ischemic heart disease (IHD) and chronic heart failure (CHF) belong to leading causes of death among patients with cardiovascular diseases (CVD). Modern medical approaches to the treatment of patients with CHF do not always provide a significant impr